Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease.
- DOI
- 10.1016/j.omtn.2026.103065
- Published
- 2026 Sep 8
- Container
- Molecular therapy. Nucleic acids
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtn.2026.103065,
title = {Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease.},
author = {van der Pluijm LAK and Koudijs A and Danser AHJ and Rotmans JI and Bijkerk R},
year = {2026},
journal = {Molecular therapy. Nucleic acids},
doi = {10.1016/j.omtn.2026.103065},
url = {https://doi.org/10.1016/j.omtn.2026.103065}
}RIS
TY - JOUR TI - Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease. AU - van der Pluijm LAK AU - Koudijs A AU - Danser AHJ AU - Rotmans JI AU - Bijkerk R PY - 2026 JO - Molecular therapy. Nucleic acids DO - 10.1016/j.omtn.2026.103065 UR - https://doi.org/10.1016/j.omtn.2026.103065 ER -
APA
LAK, V. D. P., A, K., AHJ, D., JI, R., & R, B. (2026). Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2026.103065
Source records
- pubmed · retrieved 2026-09-26T12:27:15.566Z